Executive Briefing · Strategic Capital & Partnerships
Applied software IP.
Shipping technology.
ARBH Labs engineers proprietary on-device biosignal extraction systems and precision tracking software. We eliminate cloud server dependencies by performing complex optical and acoustic signal processing directly on standard smartphone hardware.
€0.00
Marginal server compute cost per active user (100% on-device DSP)
2 Products
Production Android builds shipping today (LastDose RC11 & PulseTrace)
0% GPL
Clean-room in-house mathematical implementation with zero copyleft risk
Multi-Tier
Live monetization engine with PayPal checkout & unified activation PINs
Strategic Analysis
The 5 core investor questions.
A candid assessment of ARBH Labs' technology, defensibility, commercial roadmap, and strategic focus.
01 / TRACTION & BUILDS
What exists today?
We do not operate on unverified pitch decks. ARBH Labs has built and deployed a fully functional software ecosystem:
LastDose (v5.0.0-RC11, vc82)
Production-grade medication adherence & vital sign tracker. Features hardware-backed chronometers, event-sourced immutable timelines, and client-side zero-knowledge AES-256-GCM backups.
PulseTrace (v0.6.10-alpha)
Software-based biosignal sensing application extracting heart rate (via 6-ROI contact PPG) and respiratory rate (via differential optical flow & acoustic fusion) on standard smartphones.
Integrated Inter-App Contract
Working on-device communication layer that exports PulseTrace vital sign readings directly into LastDose logs without cloud middlemen.
Operational Monetization Stack
Cloudflare Pages API backend with PayPal order/subscription checkout, dynamic tier allocation, automated webhook provisioning, and unified 5-device license validation.
02 / DIFFERENTIATION & MOAT
What is different?
Most digital health software operates as thin cloud wrappers around remote APIs, creating massive recurring server bills, latency bottlenecks, and acute data privacy liabilities. ARBH Labs is architected differently:
Zero-Cloud Edge Compute
All image processing, Fourier analysis, and optical flow runs 100% locally on a single background executor. No raw camera frames or audio recordings leave the phone.
Tri-Spectral Consensus Engine
Instead of relying on single peak detectors, our engine runs Welch FFT periodograms, normalized lag autocorrelation, and beat-to-beat MAD peak intervals in parallel with harmonic octave correction.
Handheld Tremor Compensation
Contactless respiration uses dual-anchor differential optical flow, subtracting facial reference velocity to cancel real-world handheld vibration.
Clean-Room IP Derivation
All algorithms are implemented clean-room from published academic literature with zero copyleft (GPL/AGPL) dependencies, ensuring unencumbered ownership for commercial licensing.
03 / COMMERCIAL ROADMAP
What can this become?
Our long-term commercial opportunity extends far beyond consumer utility apps. We are architecting an embeddable mobile biosignal platform:
Modular SDK Licensing (@arbh/biosignal)
Packaging our contact PPG, optical flow, and acoustic fusion pipelines into a drop-in Android/iOS SDK for telehealth providers, remote patient monitoring (RPM) platforms, and fitness apps.
Ecosystem Cross-Pollination
Reusing our zero-knowledge cryptographic vaults, hardware chronometers, and edge-to-edge UI systems to power new local-first utilities, including local coordination (LocalFavor).
Enterprise & Clinical Trial Auditing
Providing tamper-proof, event-sourced medication tracking and physiological context logs for clinical research organizations and insurance wellness programs.
Hardware & Wearable Bridge Layers
Integrating lightweight telemetry bridges that ingest data from consumer wearables without compromising local-first privacy.
04 / EXECUTION & EFFICIENCY
Why ARBH Labs?
We combine deep systems-level software craftsmanship with extreme capital efficiency and execution speed:
Extreme Engineering Rigor
Every feature passes our mandatory 9-stage verification lifecycle, multi-threading invariants (zero math on the UI thread), and automated pre-build encoding verification.
Zero Burn Waste
We build ultra-lean software without bloated team overhead or expensive cloud dependencies. Every euro invested directly enhances proprietary technology and distribution.
Proven Shipping Cadence
Rapid, disciplined iteration across 11 release candidates for LastDose and active alpha benchmarking for PulseTrace.
Full Product Sovereignty
Complete ownership of the entire stack — from low-level Camera2 interop and DSP math to responsive web checkout and backend APIs.
05 / PARTNERSHIP & CAPITAL
What are we looking for?
We are seeking aligned strategic partners and long-term capital to accelerate commercialization:
Strategic Distribution Partners
Healthcare platforms, digital caregiver networks, and device manufacturers interested in piloting or co-distributing LastDose and PulseTrace.
SDK Pilot Customers
Digital health and fitness platforms seeking on-device vital sign estimation without per-query server costs or privacy compromises.
Value-Add Seed Capital
Funding to support hardware testing lab expansion across global Android devices, SDK productization, patent filings on novel fusion topologies, and targeted user acquisition.
Advisory & Regulatory Guidance
Advisors with deep expertise in digital health software compliance, SDK commercialization, and mobile health monetization.
Engagement Tiers
Start a strategic discussion.
Choose a topic to initiate a direct conversation with the founder. We structure partnerships around clear milestones and technical deliverables.
Distribution
Distribution & Pilots
Evaluate our shipping Android applications for your user base, explore co-marketing opportunities, or structure an enterprise pilot for caregiver networks.
Discuss Distribution →
Technology
SDK & Technology Licensing
Explore licensing the @arbh/biosignal sensing pipeline or zero-knowledge cryptographic vault for integration into your third-party mobile applications.
Discuss Licensing →
Capital
Strategic Capital
Discuss strategic seed or growth investment to accelerate SDK extraction, expand our device testing lab, and scale distribution across target markets.
Discuss Investment →
ℹ
Legal & Regulatory Notice: This overview is for informational and strategic discussion purposes only and does not constitute a public offer of securities, an investment solicitation, or a prospectus. Any commercial or investment agreement requires formal separate documentation. ARBH Labs software products are currently distributed for personal wellness and tracking purposes and are not certified medical devices.